July 15, 2019Industry News

Money in Aging Research, Part II

How much money is going into aging research? The information is not so easy to come by. This interview estimated that companies working on medical solutions to aging have a market cap of $300 billion as of 2018. Read More »

May 3, 2019Alzheimer’s

Therapy Gives New Hope For Patients with Alzheimer’s Disease

Dr. Dale Bredesen is interviewed by Juliette Goodrich CBS KPIX5 News upon the release of his study “Reversal of Cognitive Decline: 100 Patients.” Read More »

March 4, 2019Alzheimer’s, Industry News, Nutrition, Press Releases

LifeSeasons and Dr. Dale Bredesen Announce New Products to Support the Treatment of Alzheimer’s Disease and Cognitive Decline

July 26, 2018Alzheimer’s, Press Releases

AHNP Precision Health Launches the ReCODE Report

Partnering with Dr. Dale Bredesen, Alzheimer’s research pioneer and inventor of The Bredesen Protocol, AHNP Precision Health has launched the US version of the ReCODE Report, a proprietary implementation of the Bredesen Protocol which allows practitioners and individuals to achieve unprecedented success in the prevention and reversal of cognitive decline. Read More »

July 16, 2018Alzheimer’s

Interview with Dr. Dale Bredesen on ABC 7 News about reversing early Alzheimer’s symptoms

Bredesen told ABC7 during an in-studio interview, “If it’s in your family, you want to come in, in your 40’s and say, ‘where do we stand?’ We want everyone to get on prevention. We really can reduce the global burden of dementia if we do that.” Read More »

July 6, 2018Alzheimer’s, Press Releases

AHNP Precision Health Acquires MPI Cognition Dementia Business

AHNP Precision Health is announcing its acquisition of the MPI Cognition dementia business in order to rapidly bring a ground-breaking Alzheimer’s treatment protocol designed by the leading Alzheimer’s researcher to the market. Dale Bredesen MD, Founder, Co-Chairman, and Chief Science Officer of MPI Cognition is the best-selling author of the highly-acclaimed book, The End of Alzheimer’s. Read More »